Diabetes

SAN DIEGO — Children with asthma who used metformin experienced decreases in asthma-related hospitalizations and oral steroid use, according to an abstract presented at the American Thoracic Society International Conference.

BOSTON — Continuous glucose monitoring has transformed the field of diabetes over the past 25 years. The technology can be used by both providers and people with diabetes to improve disease management, according to a speaker at ENDO 2024.

Consuming more flavonoids and flavonoid-rich foods such as tea, berries and apples was associated with a lower risk for type 2 diabetes, researchers found.

Use of remdesivir in hospitalized patients with COVID-19 and reduced eGFR did not decrease the risk of major adverse cardiovascular events or major adverse kidney disease.

A miniature-sized automated insulin delivery system cleared by the FDA in 2023 is now compatible with a new-generation continuous glucose monitor, according to a press release.

The FDA has authorized CamAPS FX, a closed loop algorithm that links compatible continuous glucose monitors and insulin pumps into an artificial pancreas system for patients with type 1 diabetes aged 2 years and older.

Use of the drug semaglutide in patients with type 2 diabetes significantly reduced the risk of major kidney disease events, cardiovascular outcomes and all-cause mortality vs. placebo, newly published data show.

According to statistics reported in a recent release from Sutter Health, up to 15% of strokes are suffered by individuals aged younger than 45 years, with incidence rising.

Preliminary data show that an investigational hormone-free monthly vaginal contraceptive device successfully blocked sperm in a small open-label study recently published in Contraception.

Women with polycystic ovary syndrome, obesity and irregular menses were more than twice as likely to experience spontaneous ovulation during the year after undergoing bariatric surgery compared with medical therapy, researchers reported.